Reports in category Initiating Coverage
| Dolly Khanna is invested in Nitin Spinners. ICICI Direct has recommended a buy for the target price of Rs 290 (41% upside) | |
| Company: | Nitin Spinners |
| Brokerage: | ICICI-Direct |
| Date of report: | January 5, 2023 |
| Type of Report: | |
| Recommendation: | Buy |
| Upside Potential: | 41% |
| Summary: | Consistent improvement in financial performance of NSL in spite of cyclical nature of textile industry signifies NSL’s ability of optimum asset utilisation leading to sustainable profit growth. In line with its superior fundamental performance, the stock price has grown at 15% CAGR over last five years |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Nano Nivesh, Nitin Spinners |
| CanFin Homes is in sweet spot. Buy for target price of Rs 625: ICICI Direct | |
| Company: | Can Fin Homes |
| Brokerage: | ICICI-Direct |
| Date of report: | January 2, 2023 |
| Type of Report: | |
| Recommendation: | Buy |
| Upside Potential: | 17% |
| Summary: | Consistent business growth with focus on efficient operations coupled with relatively lower cost and strong underwriting to benefit earnings and return ratios |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Can Fin Homes, ICICI-Direct |
| Buy Gujarat Themis Biosyn for target price of Rs 909: HDFC Securities | |
| Company: | Gujarat Themis Biosyn |
| Brokerage: | HDFC Sec |
| Date of report: | January 2, 2023 |
| Type of Report: | |
| Recommendation: | Buy |
| Upside Potential: | 17% |
| Summary: | Prior to FY20, company was engaged in contract manufacturing of Rifamycin S for Lupin. During FY20, management decided to change business model from contract manufacturing to manufacturing and sales model; as a result the company’s operating profitability has significantly improved. Company had reported robust numbers over FY20-22 |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Gujarat Themis Biosyn, HDFC Sec |
| Right time to check-in Chalet Hotels. Buy for target price of Rs 455 (37% Upside): PL | |
| Company: | Chalet Hotels |
| Brokerage: | Prabhudas Lilladher |
| Date of report: | December 27, 2022 |
| Type of Report: | |
| Recommendation: | Buy |
| Upside Potential: | 37% |
| Summary: | We initiate coverage on Chalet Hotels Ltd (Chalet) with a ‘BUY’ rating, as it is a play on expected recovery in business travel complemented by an exposure to annuity business (18% share by FY25E) that acts as a hedge to deeply cyclical hospitality industry. |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Chalet Hotels, Prabhudas Lilladher |
| Indoco Remedies is an attractive investment proposition. Buy for target price of Rs 469 (24% upside): SMIFS | |
| Company: | indoco remedies |
| Brokerage: | SMIFS |
| Date of report: | December 23, 2022 |
| Type of Report: | |
| Recommendation: | Buy |
| Upside Potential: | 24% |
| Summary: | Strong business fundamentals such as diversified segments mix and strong product portfolio along with high return ratios make Indoco an attractive investment proposition |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | indoco remedies, SMIFS |
| PCBL Ltd is a carbon black giant, set to grow at a fast clip. Buy for 35% upside: SMIFS | |
| Company: | PCBL |
| Brokerage: | SMIFS |
| Date of report: | December 18, 2022 |
| Type of Report: | |
| Recommendation: | Buy |
| Upside Potential: | 35% |
| Summary: | Currently, the stock is trading at inexpensive valuation on FY25E P/E of ~9.3x. We value the stock on forward P/E multiple of 12.5x owing to increasing share of speciality business, robust volume growth & rising exports share and, thereby, arrive at target price of Rs 183 per share which offers upside of 35% from current valuations. |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | PCBL, SMIFS |
| Long Term Recommendation Carysil Ltd. Buy for target price of Rs 784 (59% upside) | |
| Company: | Acrysil, Carysil |
| Brokerage: | Edelweiss |
| Date of report: | December 13, 2022 |
| Type of Report: | |
| Recommendation: | Buy |
| Upside Potential: | 59% |
| Summary: | Carysil is well-placed for strong growth, supported by industry tailwinds, increased home improvement spending and demand for aesthetically appealing products globally. Although we saw earnings moderation in FY23 on high quartz sink inventories in the channel, we expect revenue growth to recover sharply in FY24E |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Acrysil, Carysil, Edelweiss |
| Devyani International riding on the strong business momentum in core brand business. Buy for target of Rs 220: HDFC Securities | |
| Company: | Devyani International Ltd |
| Brokerage: | HDFC Sec |
| Date of report: | November 30, 2022 |
| Type of Report: | |
| Recommendation: | Buy |
| Upside Potential: | 18% |
| Summary: | A strong recovery in the out-of-home consumption, rising traction for branded products, aggressive store expansion plans, value proposition through an innovated menu and widening delivery reach will help DIL’s revenues clock a CAGR of 36% over FY22-24E (~23% increase due to store count) |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Devyani International Ltd, HDFC Sec |
| Current valuations of RBL Bank provide for an attractive entry point for investing in the stock: Ventura | |
| Company: | RBL Bank |
| Brokerage: | Ventura |
| Date of report: | November 28, 2022 |
| Type of Report: | |
| Recommendation: | Buy |
| Upside Potential: | 70.8% |
| Summary: | In our opinion, the current valuations provide for an attractive entry point for investing in the stock with a good risk-return profile over the next 2 years. We initiate coverage on RBL with a BUY for a price target of INR 256.2 (~1.0x FY25 P/B) which represents a potential upside of 70.8% from the CMP over the next 24 months |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | RBL Bank, Ventura |
| Jubilant Foodworks Limited is a hot pick with 41% upside potential: Bonanza | |
| Company: | Jubilant Foodworks |
| Brokerage: | Bonanza |
| Date of report: | October 4, 2022 |
| Type of Report: | |
| Recommendation: | Buy |
| Upside Potential: | 41% |
| Summary: | Strong cost control and management focus on aggressive store additions along with thrust on digital & tech initiatives were key positives providing strong growth outlook. The resultant robust performance in Q1 FY23 led by strong Revenue growth, recovery in LFL growth and positive expectations from the new brands portfolio makes JFL a hot pick. |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Bonanza, Jubilant Foodworks |